RichardArandaMD

Chief Medical Officer, Gossamer Bio

Dr. Aranda is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Gastroenterology, 1992 - 1995
Los Angeles County-Harbor-UCLA Medical CenterResidency, Internal Medicine, 1986 - 1989
Stanford University School of MedicineClass of 1986

PubMed

Editorial: protecting hypoxia-inducible factor 1a and gut integrity with GB004-a promising therapeutic approach for ulcerative colitis? Authors' reply.
Silvio Danese, Barrett G Levesque, Brian G Feagan, Alina Jucov, B R Bhandari
Alimentary Pharmacology & Therapeutics. 2022-03-01
16 citations
Randomised clinical trial: a phase 1b study of GB004, an oral HIF-1α stabiliser, for treatment of ulcerative colitis.
Silvio Danese, Barrett G Levesque, Brian G Feagan, Alina Jucov, Bal Raj Bhandari
Alimentary Pharmacology & Therapeutics. 2022-02-01
12 citations
Challenges and Opportunities in IBD Clinical Trial Design
Marla Dubinsky, Rory Collins, Maria T. Abreu, Vipul Jairath, James D. Lewis
Gastroenterology. 2021-04-20

With GlaxoSmithKline in the Rearview Mirror, Abbas Hussain Is Ready to Lead a Biotech of His Own; Doug Treco Scores First CEO Job Since Ra Pharma BuyoutJune 25th, 2021
The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing DealJune 22nd, 2021
The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing DealJune 22nd, 2021
Join now to see all